AbbVie, Celgene, J&J, Merck, Pfizer and Vertex are targets of this year’s shareholder proposals citing drug pricing risks. Shareholders in six of the country’s top pharmaceutical companies will once again be asked to support a shareholder-sponsored resolution requesting a report on the degree to which executive incentive packages are tied to price increases. The companies […]
- Press Releases